Literature DB >> 21844180

Managing suicidality in home-based telehealth.

Daniel F Gros1, Kimberly Veronee, Martha Strachan, Kenneth J Ruggiero, Ron Acierno.   

Abstract

We describe the case of a US veteran from the war in Afghanistan with post-traumatic stress disorder (PTSD). The patient was undergoing treatment at home via telehealth as part of a research trial. In week six, he presented with severe suicidal ideation and required emergency hospitalization. Through a series of immediate enhanced communications (i.e. by videoconference) between the patient, patient's family, treatment team and local resources, the patient's symptoms were assessed to identify suicidality and an intervention was successfully carried out, involving the development of a safety plan and eventual transportation to an inpatient unit at the local Veterans Administration Medical Center, where he was hospitalized for three days. This demonstrates the value of telehealth in identifying and treating severe psychiatric symptoms in addition to supporting the safety of these procedures to address suicidality.

Entities:  

Mesh:

Year:  2011        PMID: 21844180     DOI: 10.1258/jtt.2011.101207

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

1.  A non-inferiority trial of Prolonged Exposure for posttraumatic stress disorder: In person versus home-based telehealth.

Authors:  Ron Acierno; Rebecca Knapp; Peter Tuerk; Amanda K Gilmore; Carl Lejuez; Kenneth Ruggiero; Wendy Muzzy; Leonard Egede; Melba A Hernandez-Tejada; Edna B Foa
Journal:  Behav Res Ther       Date:  2016-11-22

2.  Technology as a Means to Address Disparities in Mental Health Research: A Guide to "Tele-Tailoring" your Research Methods.

Authors:  Cristina M López; Suparna Qanungo; Carolyn Jenkins; Ron Acierno
Journal:  Prof Psychol Res Pr       Date:  2018-02

3.  Perceived risks and use of psychotherapy via telemedicine for patients at risk for suicide.

Authors:  Amanda K Gilmore; Erin F Ward-Ciesielski
Journal:  J Telemed Telecare       Date:  2017-10-08       Impact factor: 6.184

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.